Afleveringen
-
A two-year-old startup valued at $9.9 billion claims nearly every Nvidia engineer uses its AI code editor. Nvidia has said nothing to confirm it. The episode examines what unverifiable marketing claims reveal about the AI coding tool gold rush and the fragile economics of developer tooling.
More episodes at d33ply.xyz -
Zijn er afleveringen die ontbreken?
-
Bitso has processed over $12B in transactions across Latin America, but the bulk of its volume comes from cross-border remittances and currency hedging — not speculation. An examination of how a Mexico City crypto exchange became financial infrastructure for a region where 57% of adults lack bank accounts, and whether that parallel system can hold.
More episodes at d33ply.xyz -
Between 2023 and 2025, OpenAI deleted its weapons prohibition, appointed a former NSA director to its board, and deployed ChatGPT on classified military networks. The trajectory from AI safety nonprofit to defense partner traces a $40 billion incentive structure that made each step feel inevitable.
More episodes at d33ply.xyz -
NASA's Artemis program frames the Moon not as a rival destination to Mars but as a prerequisite — a proving ground three days from Earth where life-support failures remain survivable. The logic rests on physics, biology, and resource engineering that Mars-first advocates tend to underestimate.
More episodes at d33ply.xyz -
A programme run by former convicted hackers is recruiting secondary school students in Manchester, redirecting young technical talent toward cybersecurity careers before the criminal justice system intervenes. With 3.5 million unfilled cybersecurity positions projected by 2026, the initiative tests a discomforting premise: the skills that produce elite defenders and dangerous criminals are identical.
More episodes at d33ply.xyz -
A multi-cancer early detection test backed by £150 million in NHS funding is nearing its first large-scale results from 140,000 participants. The trial could reshape screening for dozens of cancers that currently go undetected until late stages — or expose the limits of liquid biopsy technology.
More episodes at d33ply.xyz -
New 2026 Medicare reimbursement rules tie behavioral health payments to demonstrated patient outcomes for the first time. After decades of intuition-driven practice, therapists and telehealth startups face a measurement-based care mandate that could reshape how mental health treatment is delivered and funded.
More episodes at d33ply.xyz -
Boston Scientific is paying ten times revenue to acquire Penumbra, a maker of mechanical thrombectomy devices used in 180,000 procedures last year. The deal signals that independent medtech companies face a scaling ceiling — and that the era of consolidation in life-saving hardware has arrived.
More episodes at d33ply.xyz
